Vikramaditya Gangakar/LinkedIn
Jun 8, 2026, 14:45
Vikramaditya Gangakar: A Comprehensive Overview of Enoxaparin
Vikramaditya Gangakar, Pharmacy Technician at Ain Al Khaleej Hospital, shared a post on LinkedIn:
“365 Drugs/365 Days Pharmacy Mastery Challenge
Day 55 Drug – Enoxaparin (Clexane®)
Drug Snapshot
- Generic Name: Enoxaparin Sodium
- Brand: Clexane®/Lovenox®
- Class: Low Molecular Weight Heparin (LMWH)
- Route: Subcutaneous (SC), IV (selected ACS cases)
- Prescription: Rx Only
Mechanism of Action
- Enhances Antithrombin III activity
- Primarily inhibits Factor Xa
- Mild inhibition of Thrombin (Factor IIa)
- Prevents formation and growth of blood clots.
Main Uses
- Acute Coronary Syndrome (ACS)
- Deep Vein Thrombosis (DVT)
- Pulmonary Embolism (PE)
- Post-operative thrombosis prevention
- Anticoagulation bridging therapy
Key Adult Doses
- DVT Prophylaxis: 40 mg SC once daily
- DVT/PE Treatment: 1 mg/kg SC every 12 hrs or 1.5 mg/kg SC once daily
- CrCl less than 30 mL/min: Dose adjustment required
Contraindications
- Active major bleeding
- History of HIT (Heparin-Induced Thrombocytopenia)
- Severe thrombocytopenia
- Hypersensitivity to heparins
Common Adverse Effects
- Injection-site bruising/pain
- Bleeding
- Thrombocytopenia
- Elevated liver enzymes
Serious
- Major hemorrhage
- HIT
- Spinal/Epidural hematoma
Monitoring
- CBC (Hb, Hct, Platelets)
- Signs of bleeding
- Renal function (SCr, CrCl)
- Anti-Xa levels (special populations)
Major Interactions
- Aspirin
- NSAIDs
- Warfarin
- Clopidogrel/Ticagrelor
- Thrombolytics
- Increased bleeding risk
Patient Counseling
- Inject into abdomen fat layer
- Rotate injection sites
- Do not rub after injection
- Do not expel air bubble from prefilled syringe
- Seek medical help for unusual bleeding, black stools, or blood in urine
Pharmacy Pearl
LMWH of choice for DVT/PE treatment and prophylaxis. Routine aPTT monitoring is not required (unlike unfractionated heparin).
Memory Trick
‘ENOXA = Xa Blocker’ Enoxaparin – Factor Xa – Clot Formation
Exam Point
Enoxaparin causes less hit and has more predictable anticoagulation than unfractionated heparin.”
Stay updated with Hemostasis Today.
-
Oct 22, 2026, 14:45Seyed Mehrab Safdari: Prenatal Diagnosis in Hemophilia – Two Decades of Progress and Remaining Challenges
-
Oct 22, 2026, 14:39Mahmoud Abdelnabi: Evaluating the Evidence on Elevated Lp(a) and VTE Before Clinical Translation
-
Oct 22, 2026, 14:34David McIntosh: Fundamental Flaws in National Blood Systems Are Root Causes of Failure
-
Oct 22, 2026, 14:32Aurelio Maggio: Bridging Scientific Progress and Equitable Access to SCD Care in Sub-Saharan Africa
-
Oct 22, 2026, 14:26Khaled Musallam: Longevity and Healthy Aging in Thalassemia
-
Oct 22, 2026, 14:26Deise Catamo Vaz: Two Years of Growth and a New Way of Seeing the World of Stroke
-
Oct 22, 2026, 14:24Yara Mohamed: A Silent Killer Plots his Victim’s Death Over Years
-
Oct 22, 2026, 14:19Shailendra Singh: Two Different Pulmonary Embolism Cases, One Critically Important Lesson
-
Oct 22, 2026, 14:14Caitlin Raymond: Estimating Infection Rates After Therapeutic Plasma Exchange in a Large Real-World Population